Evolving management options for pancreatic neuroendocrine tumors to be reviewed
Growing evidence suggests that pancreatic neuroendocrine tumors (PNET) are more common than previously thought. Four experts will discuss the latest data during Sunday’s DDW Clinical Symposium Recent Advances in Neuroendocrine Tumors of the Pancreas, which is jointly sponsored by AGA and SSAT.